Skip to main content
SpringerLink
Log in

Coxibe

Coxibs

  • Leitthema: Meilensteine in der Rheumatologie: 75 Bände Innovation
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Bolten WW, Lang B, Wagner AV et al (1999) Consequences and costs of NSAID-gastropathy in Germany. Akt Rheumatol 24:127–134

    Article  Google Scholar 

  2. Bolten WW, Kruger K, Reiter-Niesert S et al (2016) DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain. Z Rheumatol 75:103–116

    Article  CAS  PubMed  Google Scholar 

  3. Bombardier C, Laine L, Reicin A et al (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343:1520–1528

    Article  CAS  PubMed  Google Scholar 

  4. Catella-Lawson F, Reilly MP, Kapoor SC et al (2001) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809–1817

    Article  CAS  PubMed  Google Scholar 

  5. Conaghan PG (2012) A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int 32:1491–1502

    Article  CAS  PubMed  Google Scholar 

  6. Coxib and Traditional Nsaid Trialists’ (Cnt) Collaboration (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382:769–779

    Article  Google Scholar 

  7. Douthwaite AH, Lintott GAM (1938) Gastroscopic observation of the effect of aspirin and certain other substances on the stomach. Lancet 2:1222–1225

    Article  Google Scholar 

  8. Gomm W, Von Holt K, Thome F et al (2016) Association of proton pump inhibitors with risk of dementia: A pharmacoepidemiological claims data analysis. JAMA Neurol 73:410–416

    Article  PubMed  Google Scholar 

  9. Lindhardsen J, Gislason GH, Jacobsen S et al (2014) Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. Ann Rheum Dis 73:1515–1521

    Article  CAS  Google Scholar 

  10. Mitchell JA, Warner TD (1999) Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol 128:1121–1132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Poddubnyy D, Rudwaleit M, Haibel H et al (2012) Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 71:1616–1622

    Article  CAS  PubMed  Google Scholar 

  12. Roubille C, Richer V, Starnino T et al (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74:480–489

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Silverstein FE, Graham DY, Senior JR et al (1995) Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123:241–249

    Article  CAS  PubMed  Google Scholar 

  14. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232–235

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatologie, Klaus-Miehlke Klinik, Leibnizstr. 23, 65191, Wiesbaden, Deutschland

    W. W. Bolten

  2. Praxiszentrum St. Bonifatius, St.-Bonifatius-Str. 5, 81541, München, Deutschland

    K. Krüger

Authors
  1. W. W. Bolten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. W. Bolten.

Ethics declarations

Interessenkonflikt

W.W. Bolten und K. Krüger geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

U. Müller-Ladner, Bad Nauheim

H.-M. Lorenz, Heidelberg

M. Schneider, Düsseldorf

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bolten, W.W., Krüger, K. Coxibe. Z Rheumatol 75, 595–598 (2016). https://doi.org/10.1007/s00393-016-0148-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-016-0148-5

Search

Navigation